RaySearch Laboratories AB (publ)

Stockholm Stock Exchange RAY-B.ST

RaySearch Laboratories AB (publ) Gross Profit for the year ending December 31, 2023: USD 90.37 M

RaySearch Laboratories AB (publ) Gross Profit is USD 90.37 M for the year ending December 31, 2023, a 26.39% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • RaySearch Laboratories AB (publ) Gross Profit for the year ending December 31, 2022 was USD 71.50 M, a 9.83% change year over year.
  • RaySearch Laboratories AB (publ) Gross Profit for the year ending December 31, 2021 was USD 65.10 M, a -11.69% change year over year.
  • RaySearch Laboratories AB (publ) Gross Profit for the year ending December 31, 2020 was USD 73.72 M, a 3.53% change year over year.
  • RaySearch Laboratories AB (publ) Gross Profit for the year ending December 31, 2019 was USD 71.20 M, a 10.81% change year over year.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
Loading...
Stockholm Stock Exchange: RAY-B.ST

RaySearch Laboratories AB (publ)

CEO Dr. Johan Lof Ph.D.
IPO Date Jan. 3, 2000
Location Sweden
Headquarters Sveavägen 44
Employees 411
Sector Health Care
Industries
Description

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.

Similar companies

BIOT.ST

Biotage AB (publ)

USD 11.98

-2.51%

VITR.ST

Vitrolife AB (publ)

USD 18.25

2.79%

PROB.ST

Probi AB (publ)

USD 31.10

0.68%

EKTA-B.ST

Elekta AB (publ)

USD 5.39

-0.39%

CEVI.ST

CellaVision AB (publ)

USD 18.76

3.89%

StockViz Staff

January 15, 2025

Any question? Send us an email